MEA Bioinformatics Market - Industry Trends Forecast to 2029
- Published Date: 2022-12-22
- Report ID: 143120
- Pages: 225
-
Format:
Short Description:
Middle East and Africa bioinformatics market, By Type (Knowledge management tools (generalized knowledge management tools, specialized knowledge management tools), Bioinformatics software (informatics infrastructure and pipeline setup, sample and experiment management, sequencing data analysis (sequence analysis platform, sequence alignment platform, sequence manipulation platform, structural analysis platform)) Biological data interpretation, specialized bioinformatics application (single cell gene expression, gene expression, variant detection, CNV analysis, metagenomics, methylation, chip-seq, non-coding RNA expression and others), Services), Sector (medical biotechnology, academics, animal biotechnology, agricultural biotechnology, environmental biotechnology, forensic biotechnology and others), Application( Genomics & Drug Development (knowledge management tools, bioinformatics software, services, by type(preventive medicine, molecular medicine, personalized medicine, chemo-informatics and drug design, antibiotic resistance) Proteomics (knowledge management tools, bioinformatics software, services), Evolutionary studies (knowledge management tools, bioinformatics software, services), Agricultural studies(knowledge management tools, bioinformatics software, services), Veterinary Science (knowledge management tools, bioinformatics software, services), Metabolomics (knowledge management tools, bioinformatics software, services), Transcriptomics(knowledge management tools, bioinformatics software, services) and others (knowledge management tools, bioinformatics software, services), Purchase mode (group purchase and individual purchase), Genomics (Genomics (DNA and RNA), Proteomics) End User (Research and academic institute, Clinical research organization, biotech and pharmaceutical companies, research laboratories, hospitals and Others.) Country (South Africa, UAE, Egypt, Saudi Arabia, Israel, Rest of the Middle East & Africa) Industry Trends & Forecast to 2029.
Market Definition:
Bioinformatics, which is connected to genetics and genomics, uses computer technology to gather, store, analyze, and share biological data and information, such as DNA and amino acid sequences or annotations about those sequences. The three components of bioinformatics are building databases, creating statistics and algorithms, data analysis, and interpretation. Identification of genes and proteins, as well as their functions, evolutionary relationships, and conformation prediction, are the main goals.
For instance,
In December 2021, Seven Bridges Genomics, had launched the Unified Patient Network, to facilitate personalized medicine and patient care. The Unified Patient Network (UPN) operates as a cooperative group with non-profit academic health centers
The drivers responsible for the growth of the Middle East and Africa bioinformatics market are increased use of bioinformatics equipment, decrease in the cost of genetic sequencing per base, technological advancements in the bioinformatics devices, and wide product portfolio offered by major players. However, the rise in the cost of devices, risks observed while using the devices, difficulty in using bioinformatics devices, and cybersecurity concerns in bioinformatics is expected to restrain the market growth.
On the other hand, strategic initiatives by key players, a rise in healthcare expenditure, and an increase in research and development activities may act as an opportunity for the growth of the global bioinformatics market. However, the need for skilled expertise and regulatory approval may create challenges for the global bioinformatics market.
Market Segmentation:
The Middle East and Africa bioinformatics market is categorized into six segments: type, sector, application, purchase mode, genomics, and end user.
On the basis of type, the Middle East and Africa bioinformatics market is segmented into Knowledge management tools (generalized knowledge management tools, specialized knowledge management tools), Bioinformatics software (informatics infrastructure and pipeline setup, sample and experiment management, sequencing data analysis (sequence analysis platform, sequence alignment platform, sequence manipulation platform, structural analysis platform) Biological data interpretation, specialized bioinformatics application (single-cell gene expression, gene expression, variant detection, CNV analysis, metagenomics, methylation, chip-seq, non-coding RNA expression, and others), Services)
On the basis of sector, the Middle East and Africa bioinformatics market is segmented into medical biotechnology, academics, animal biotechnology, agricultural biotechnology, environmental biotechnology, forensic biotechnology, and others.
On the basis of application, Genomics & Drug Development (knowledge management tools, bioinformatics software, services, by type(preventive medicine, molecular medicine, personalized medicine, chemo-informatics, and drug design, antibiotic resistance) Proteomics (knowledge management tools, bioinformatics software, services), Evolutionary studies (knowledge management tools, bioinformatics software, services), Agricultural studies(knowledge management tools, bioinformatics software, services), Veterinary Science (knowledge management tools, bioinformatics software, services), Metabolomics (knowledge management tools, bioinformatics software, services), Transcriptomics(knowledge management tools, bioinformatics software, services) and others (knowledge management tools, bioinformatics software, services).
On the basis of purchase mode, the Middle East and Africa bioinformatics market is segmented into group purchases and individual purchases.
On the basis of genomics, the Middle East and Africa bioinformatics market is segmented into Genomics (DNA and RNA) and Proteomics.
On the basis of end-user, the Middle East and Africa bioinformatics market is segmented into Research and academic institute, Clinical research organizations, biotech and pharmaceutical companies, research laboratories, hospitals, and others.
Market Players:
The key market players operating in the Middle East and Africa bioinformatics market are listed below:
Thermo Fisher Scientific
Illumina, Inc
Agilent Technologies, Inc
QIAGEN
SOPHiA GENETICS
BGI
Bayer AG
DNANEXUS, INC
PerkinElmer Inc.
Seven Bridges Genomics
Quest Diagnostics Incorporated
AstridBio Technologies Inc
BioBam
Strand Life Sciences
GenoFAB, Inc
TABLE OF CONTENTS
1 INTRODUCTION 52
1.1 OBJECTIVES OF THE STUDY 52
1.2 MARKET DEFINITION 52
1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA BIOINFORMATICS MARKET 52
1.4 CURRENCY AND PRICING 55
1.5 LIMITATION 55
1.6 MARKETS COVERED 55
2 MARKET SEGMENTATION 59
2.1 MARKETS COVERED 59
2.2 GEOGRAPHIC SCOPE 60
2.3 YEARS CONSIDERED FOR THE STUDY 61
2.4 CURRENCY AND PRICING 61
2.5 RESEARCH METHODOLOGY 62
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 65
2.7 MULTIVARIATE MODELLING 66
2.8 TYPE SEGMENT LIFELINE CURVE 66
2.9 DBMR MARKET POSITION GRID 67
2.10 VENDOR SHARE ANALYSIS 69
2.11 MARKET APPLICATION COVERAGE GRID 70
2.12 THE CATEGORY VS TIME GRID 71
2.13 SECONDARY SOURCES 72
2.14 ASSUMPTIONS 72
3 EXECUTIVE SUMMARY 73
4 PREMIUM INSIGHTS 77
4.1 PESTEL 79
4.2 PORTER'S FIVE FORCES MODEL 80
5 REGULATIONS OF THE MIDDLE EAST & AFRICA BIOINFORMATICS MARKET 81
6 MARKET OVERVIEW 84
6.1 DRIVERS 86
6.1.1 DECREASE IN THE COST OF GENETIC SEQUENCING PER BASE 86
6.1.2 GROWING NEED FOR BIOINFORMATICS 87
6.1.3 WIDE PRODUCT PORTFOLIO OFFERED BY MAJOR PLAYERS 88
6.1.4 USE OF BIOINFORMATICS IN PERSONALIZED MEDICINE 89
6.1.5 INCREASING PUBLIC-PRIVATE SECTOR FUNDING FOR BIOINFORMATICS 89
6.2 RESTRAINTS 90
6.2.1 HIGH COST OF INSTRUMENTATION 90
6.2.2 DIFFICULTY IN CLINICAL BIOINFORMATICS ANALYSIS 90
6.2.3 CYBER SECURITY CONCERNS IN BIOINFORMATICS 91
6.3 OPPORTUNITIES 91
6.3.1 STRATEGIC INITIATIVES BY THE KEY MARKET PLAYER 91
6.3.2 PRODUCT DEVELOPMENT IN RECENT YEARS 92
6.3.3 ADVANCEMENT IN BIOINFORMATICS TECHNOLOGY 92
6.4 CHALLENGES 93
6.4.1 LACK OF SKILLED PROFESSIONALS TO PERFORM BIOINFORMATICS TECHNOLOGY 93
6.4.2 CHALLENGES TO IMPLEMENTING BIOINFORMATICS TECHNOLOGY IN THE CLINICAL LABS 93
7 MIDDLE EAST & AFRICA BIOINFORMATICS MARKET, BY TYPE 95
7.1 OVERVIEW 96
7.2 SERVICES 99
7.2.1 DIAGNOSTICS CONSULTATION 100
7.2.2 DATA ANALYSIS 100
7.2.2.1 STRUCTURAL 100
7.2.2.2 FUNCTIONAL 100
7.3 BIOINFORMATICS SOFTWARE 100
7.3.1 INFORMATICS INFRASTRUCTURE AND PIPELINE SETUP 102
7.3.2 SAMPLE AND EXPERIMENT MANAGEMENT 102
7.3.3 SEQUENCING DATA ANALYSIS 102
7.3.3.1 SEQUENCE ANALYSIS PLATFORM 103
7.3.3.2 SEQUENCE ALIGNMENT PLATFORM 103
7.3.3.3 SEQUENCE MANIPULATION PLATFORM 103
7.3.3.4 STRUCTURAL ANALYSIS PLATFORM 103
7.3.3.5 OTHERS 103
7.3.4 BIOLOGICAL DATA INTERPRETATION 103
7.3.5 SPECIALIZED BIOINFORMATICS APPLICATIONS 104
7.3.5.1 SINGLE CELL GENE EXPRESSION 104
7.3.5.2 GENE EXPRESSION 104
7.3.5.3 VARIANT DETECTION 104
7.3.5.4 CNV ANALYSIS 104
7.3.5.5 METAGENOMICS 105
7.3.5.6 METHYLATION 105
7.3.5.7 CHIP-SEQ 105
7.3.5.8 NON-CODING RNA EXPRESSION 105
7.3.5.9 OTHERS 105
7.3.6 OTHERS 105
7.4 KNOWLEDGE MANAGEMENT TOOLS 105
7.4.1 GENERALIZED KNOWLEDGE MANAGEMENT TOOLS 106
7.4.2 SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS 106
8 MIDDLE EAST & AFRICA BIOINFORMATICS MARKET, BY SECTOR 107
8.1 OVERVIEW 108
8.2 MEDICAL BIOTECHNOLOGY 111
8.3 ACADEMICS 112
8.4 ANIMAL BIOTECHNOLOGY 113
8.5 AGRICULTURAL BIOTECHNOLOGY 113
8.6 ENVIRONMENTAL BIOTECHNOLOGY 114
8.7 FORENSIC BIOTECHNOLOGY 115
8.8 OTHERS 116
9 MIDDLE EAST & AFRICA BIOINFORMATICS MARKET, BY APPLICATION 117
9.1 OVERVIEW 118
9.2 GENOMICS & DRUG DEVELOPMENT 121
9.2.1 SERVICES 122
9.2.2 SEQUENCING PLATFORMS 122
9.2.3 KNOWLEDGE MANAGEMENT TOOLS 122
9.2.4 GENOMICS & DRUG DEVELOPMENT BY TYPE 123
9.2.4.1 PREVENTIVE MEDICINE 123
9.2.4.2 MOLECULAR MEDICINE 123
9.2.4.3 PERSONALIZED MEDICINE 123
9.2.4.4 CHEMOINFORMATICS AND DRUG DESIGN 123
9.2.4.5 ANTIBIOTIC RESISTANCE 123
9.3 PROTEOMICS 123
9.3.1 SERVICES 125
9.3.2 SERVICES SEQUENCING PLATFORMS 125
9.3.3 KNOWLEDGE MANAGEMENT TOOLS 125
9.4 AGRICULTURAL STUDIES 125
9.4.1 SERVICES 127
9.4.2 SERVICES SEQUENCING PLATFORMS 127
9.4.3 KNOWLEDGE MANAGEMENT TOOLS 127
9.5 TRANSCRIPTOMICS 127
9.5.1 SERVICES 128
9.5.2 SERVICES SEQUENCING PLATFORMS 128
9.5.3 KNOWLEDGE MANAGEMENT TOOLS 128
9.6 METABOLOMICS 128
9.6.1 SERVICES 130
9.6.2 SERVICES SEQUENCING PLATFORMS 130
9.6.3 KNOWLEDGE MANAGEMENT TOOLS 130
9.7 EVOLUTIONARY STUDIES 130
9.7.1 SERVICES 131
9.7.2 SERVICES SEQUENCING PLATFORMS 131
9.7.3 KNOWLEDGE MANAGEMENT TOOLS 131
9.8 VETERINARY SCIENCE 131
9.8.1 SERVICES 133
9.8.2 SERVICES SEQUENCING PLATFORMS 133
9.8.3 KNOWLEDGE MANAGEMENT TOOLS 133
9.9 OTHERS 133
9.9.1 SERVICES 135
9.9.2 SERVICES SEQUENCING PLATFORMS 135
9.9.3 KNOWLEDGE MANAGEMENT TOOLS 135
10 MIDDLE EAST & AFRICA BIOINFORMATICS MARKET, BY PURCHASE MODE 136
10.1 OVERVIEW 137
10.2 GROUP PURCHASE 140
10.3 INDIVIDUAL PURCHASE 140
11 MIDDLE EAST & AFRICA BIOINFORMATICS MARKET, BY METHOD 142
11.1 OVERVIEW 143
11.2 GENOMICS 146
11.2.1 DNA 147
11.2.2 RNA 147
11.3 PROTEOMICS 147
12 MIDDLE EAST & AFRICA BIOINFORMATICS MARKET, BY END USER 149
12.1 OVERVIEW 150
12.2 RESEARCH AND ACADEMIC INSTITUTES 153
12.3 CLINICAL RESEARCH ORGANIZATION 153
12.4 BIOTECH AND PHARMACEUTICAL COMPANIES 154
12.5 RESEARCH LABORATORIES 155
12.6 HOSPITALS 156
12.7 OTHERS 157
13 MIDDLE EAST & AFRICA BIOINFORMATICS MARKET, BY REGION 158
13.1 MIDDLE EAST AND AFRICA 159
13.1.1 SOUTH AFRICA 170
13.1.2 U.A.E 176
13.1.3 EGYPT 182
13.1.4 SAUDI ARABIA 188
13.1.5 ISRAEL 194
13.1.6 REST OF MIDDLE EAST AND AFRICA 200
14 MIDDLE EAST & AFRICA BIOINFORMATICS MARKET: COMPANY LANDSCAPE 201
14.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 201
15 SWOT ANALYSIS 202
16 COMPANY PROFILE 203
16.1 BAYER AG 203
16.1.1 COMPANY SNAPSHOT 203
16.1.2 REVENUE ANALYSIS 203
16.1.3 COMPANY SHARE ANALYSIS 204
16.1.4 PRODUCT PORTFOLIO 204
16.1.5 RECENT DEVELOPMENTS 204
16.2 THERMO FISHER SCIENTIFIC INC 205
16.2.1 COMPANY SNAPSHOT 205
16.2.2 REVENUE ANALYSIS 205
16.2.3 COMPANY SHARE ANALYSIS 206
16.2.4 PRODUCT PORTFOLIO 206
16.2.5 RECENT DEVELOPMENTS 206
16.3 EUROFINS SCIENTIFIC 207
16.3.1 COMPANY SNAPSHOT 207
16.3.2 REVENUE ANALYSIS 207
16.3.3 COMPANY SHARE ANALYSIS 208
16.3.4 PRODUCT PORTFOLIO 208
16.3.5 RECENT DEVELOPMENTS 208
16.4 DASSAULT SYSTMES 209
16.4.1 COMPANY SNAPSHOT 209
16.4.2 REVENUE ANALYSIS 209
16.4.3 COMPANY SHARE ANALYSIS 210
16.4.4 PRODUCT PORTFOLIO 210
16.4.5 RECENT DEVELOPMENTS 210
16.5 AGILENT TECHNOLOGIES, INC 211
16.5.1 COMPANY SNAPSHOT 211
16.5.2 REVENUE ANALYSIS 211
16.5.3 COMPANY SHARE ANALYSIS 212
16.5.4 PRODUCT PORTFOLIO 212
16.5.5 RECENT DEVELOPMENTS 213
16.6 ASTRIDBIO TECHNOLOGIES INC. 214
16.6.1 COMPANY SNAPSHOT 214
16.6.2 PRODUCT PORTFOLIO 214
16.6.3 RECENT DEVELOPMENTS 214
16.7 BGI (A SUBSIDIARY OF BGI GROUP) 215
16.7.1 COMPANY SNAPSHOT 215
16.7.2 PRODUCT PORTFOLIO 215
16.7.3 RECENT DEVELOPMENTS 216
16.8 BIOBAM 217
16.8.1 COMPANY SNAPSHOT 217
16.8.2 PRODUCT PORTFOLIO 217
16.8.3 RECENT DEVELOPMENTS 217
16.9 DNANEXUS INC. 219
16.9.1 COMPANY SNAPSHOT 219
16.9.2 PRODUCT PORTFOLIO 219
16.9.3 RECENT DEVELOPMENTS 219
16.10 DNASTAR 220
16.10.1 COMPANY SNAPSHOT 220
16.10.2 PRODUCT PORTFOLIO 220
16.10.3 RECENT DEVELOPMENTS 220
16.11 GENOFAB, INC 221
16.11.1 COMPANY SNAPSHOT 221
16.11.2 PRODUCT PORTFOLIO 221
16.11.3 RECENT DEVELOPMENTS 221
16.12 ILLUMINA, INC 222
16.12.1 COMPANY SNAPSHOT 222
16.12.2 REVENUE ANALYSIS 222
16.12.3 PRODUCT PORTFOLIO 223
16.12.4 RECENT DEVELOPMENTS 223
16.13 PARTEK INCORPORATED 224
16.13.1 COMPANY SNAPSHOT 224
16.13.2 PRODUCT PORTFOLIO 224
16.13.3 RECENT DEVELOPMENTS 224
16.14 PERKINELMER INC. 225
16.14.1 COMPANY SNAPSHOT 225
16.14.2 PRODUCT PORTFOLIO 225
16.14.3 RECENT DEVELOPMENTS 226
16.15 QIAGEN 227
16.15.1 COMPANY SNAPSHOT 227
16.15.2 REVENUE ANALYSIS 227
16.15.3 PRODUCT PORTFOLIO 227
16.15.4 RECENT DEVELOPMENTS 228
16.16 QUEST DIAGNOSTICS INCORPORATED (2021) 229
16.16.1 COMPANY SNAPSHOT 229
16.16.2 REVENUE ANALYSIS 229
16.16.3 PRODUCT PORTFOLIO 230
16.16.4 RECENT DEVELOPMENTS 230
16.17 SEVEN BRIDGES GENOMICS 231
16.17.1 COMPANY SNAPSHOT 231
16.17.2 PRODUCT PORTFOLIO 231
16.17.3 RECENT DEVELOPMENTS 231
16.18 SOPHIA GENETICS 232
16.18.1 COMPANY SNAPSHOT 232
16.18.2 REVENUE ANALYSIS 232
16.18.3 PRODUCT PORTFOLIO 233
16.18.4 RECENT DEVELOPMENTS 233
16.19 STRAND LIFE SCIENCES 234
16.19.1 COMPANY SNAPSHOT 234
16.19.2 PRODUCT PORTFOLIO 234
16.19.3 RECENT DEVELOPMENTS 235
16.20 WATERS CORPORATION 236
16.20.1 COMPANY SNAPSHOT 236
16.20.2 PRODUCT PORTFOLIO 236
16.20.3 RECENT DEVELOPMENTS 236
17 QUESTIONNAIRE 237
18 RELATED REPORTS 241
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
